Dorman Products (NASDAQ: DORM) reported Q1 EPS of $1.29, $0.08 better than the analyst estimate of $1.21. Revenue for the quarter came in at $401.6 million versus the consensus estimate of $371.84 million.

GUIDANCE:

Dorman Products sees FY2022 EPS of $5.35-$5.55, versus the consensus of $5.49.

• The Company is reaffirming its fiscal 2022 guidance of net sales growth of 19% to 22%, diluted EPS of $4.94 to $5.14, and adjusted diluted EPS* of $5.35 to $5.55.

For earnings history and earnings-related data on Dorman Products (DORM) click here.